1998
DOI: 10.7326/0003-4819-129-11_part_1-199812010-00009
|View full text |Cite
|
Sign up to set email alerts
|

Drug-Induced Thrombocytopenia

Abstract: Many reports of drug-induced thrombocytopenia do not provide evidence supporting a definite or probable causal relation between the disease and the drug. Future patient case reports should incorporate standard criteria to clearly establish the etiologic role of the drug.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
90
0
1

Year Published

2003
2003
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 435 publications
(101 citation statements)
references
References 13 publications
3
90
0
1
Order By: Relevance
“…Drug-dependent antiplatelet antibody assays, where available, are not well standardized [7]. Ultimately the diagnosis of drug-induced thrombocytopenia is by exclusion [8].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Drug-dependent antiplatelet antibody assays, where available, are not well standardized [7]. Ultimately the diagnosis of drug-induced thrombocytopenia is by exclusion [8].…”
Section: Discussionmentioning
confidence: 99%
“…Ultimately the diagnosis of drug-induced thrombocytopenia is by exclusion [8]. The primary treatment for DITP is to discontinue the suspected drug [7]. Patients at risk of life-threatening bleeding may benefit from intravenous immunoglobulin therapy, plasmapheresis and platelet transfusion.…”
Section: Discussionmentioning
confidence: 99%
“…Current understanding of pathogenesis is lacking with several mechanisms described for different medications [2]. Criteria have been published to evaluate potential causality for drugs implicated in DITP [3]. In our study patient, the medication fulfilled 3 of 4 criteria providing a “level II” evidence of causality as well as fitting within the expected time course [2, 3].…”
mentioning
confidence: 99%
“…Criteria have been published to evaluate potential causality for drugs implicated in DITP [3]. In our study patient, the medication fulfilled 3 of 4 criteria providing a “level II” evidence of causality as well as fitting within the expected time course [2, 3]. For the maximum level I strength of causality to be achieved, a rechallenge to suspected offending medication is required, which in most instances is impractical and unethical [3].…”
mentioning
confidence: 99%
See 1 more Smart Citation